Recent advancements in HIV research are showing promising results. The RIO trial, led by Imperial College London, assessed the impact of two long-acting immune therapies known as broadly neutralizing antibodies (bNAbs) among 68 people living with HIV. The trial results revealed that three-quarters of participants who received the bNAbs were able to control the virus […]
Recent advancements in HIV research are bringing us closer to a “functional cure.” At the Conference on Retroviruses and Opportunistic Infections (CROI) 2025, Gilead Sciences presented groundbreaking data from its innovative HIV treatment portfolio. The new findings highlight a transformative portfolio and a rapidly advancing pipeline focused on expanding choices and enhancing outcomes for those […]
“Impairment of immunological and neurological synapses by respiratory viruses. Implications for vaccine design” Prof. Alexis KalergisFull Professor, Schools of Biological Sciences and Medicine, Pontificia Universidad Católica de ChileDoctor on Microbiology and Immunology, Albert Einstein College of Medicine, New York
“Nutrient Competition in the Gut: From Molecular Principles to Novel Therapies” Prof. Till Strowig Head, Department of Microbial Immune Regulation, Helmholtz Centre for Infection Research (HZI)
Sponsored by the Stavros Niarchos Foundation Institute for Global Infectious Disease Research and The Maurice R. and Corinne P. Greenberg Center for the Study of Inflammation, Microbiome, and Metabolism On October 15-16, 2024, the retreat took place at the Edith Macy Center in Briarcliff Manor, NY. Twenty-Four University laboratories gathered in an informal setting to […]
“Bioethical Implications of Prenatal Testing” Vardit Ravitsky, Ph.D.President and CEO, The Hastings Center
“A Tale of Betrayal: Host Proteins and Their Complex Role in Facilitating Viral infection” Hans-Heinrich Hoffmann, Ph.D.Research Associate, Laboratory of Virology and Infectious Disease, Rockefeller University
In a new publication, SNF Institute investigators Jeff Ravetch and Stylianos Bournazos found that in humans, the antibodies elicited by their new vaccine candidate rely on interactions with specific immune receptors known to give protection against viral diseases. These findings are consistent with their previous findings. Knowing this helps us get closer to designing universal flu […]
“Is a Functional Cure a Possibility for Chronic Hepatitis B? Key Learnings from Bepirovirsen Clinical and Preclinical Studies” Shihyun You, PhD Executive Director, GSK
Chaired by SNF Institute Director Charles M. Rice, PhD – 30 seminars and 16 posters representing the full range of SNF-funded infectious disease research and global partnerships at the Rockefeller University.
